Using Modified RECIST and Alpha-Fetoprotein Levels to Assess Treatment Benefit in Hepatocellular Carcinoma

BACKGROUND AND AIMS: Assessing treatment responses in hepatocellular carcinoma (HCC) is challenging, and alternative radiologic methods of measuring treatment response are required. Modified Response Evaluation Criteria in Solid Tumors (mRECIST) for HCC and alpha-fetoprotein (AFP) levels were assess...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Liver Cancer
Main Authors: Raoul, Jean-Luc, Park, Joong-Won, Kang, Yoon-Koo, Finn, Richard S, Kim, Jun Suk, Yeo, Winnie, Polite, Blasé N, Chao, Yee, Walters, Ian, Baudelet, Christine, Lencioni, Riccardo
Formato: Artigo
Idioma:Inglês
Publicado: S. Karger AG 2014
Assuntos:
Review
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4531422/
https://ncbi.nlm.nih.gov/pubmed/26280005
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000343872
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares